TrialRespiratory research2022

Long-term evaluation of the safety and efficacy of recombinant human pentraxin-2 (rhPTX-2) in patients with idiopathic pulmonary fibrosis (IPF): an open-label extension study.

Ganesh Raghu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.